Charlie Schmidt. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » HumansLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/immunologyPractice Guidelines as Topic/standardsProtein Kinase Inhibitors/therapeutic useWithholding Treatment/standards
Substances: See more » Protein Kinase Inhibitors
Year: 2017 PMID: 29982761 DOI: 10.1093/jnci/djx154
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506